M&G »

Arcutis Biotherapeutics shares owned by M&G

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by M&G from 13F filings

Historical chart of M&G investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by M&G consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by M&G

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 469k 24.00

More positions owned by M&G

Microsoft Corporation (MSFT)
Amcor Com New (AMCR)
Astrazeneca Ord (AZN)
Methanex Corp (MEOH)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
V.F. Corporation (VFC)
Nextera Energy (NEE)
Broadcom (AVGO)
Bristol Myers Squibb (BMY)
Wells Fargo & Company (WFC)
Medtronic SHS (MDT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Equinix (EQIX)

View all positions for M&G

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Polar Capital Holdings
State Street Corporation
Jennison Associates
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Driehaus Capital Management
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics